arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Synergy CHC Corp.

SNYR
$0.17 0.00 (+0.24%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
10 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
54
Health
Fair
Neutral
auto_awesome

Analytical Summary

Synergy CHC Corp. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Operating Margin (%) and Profit Margin (%) which show concerning trends. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $1.7M
Dividend Yield
Revenue Growth -12.8%
Op. Margin -27.8%
ROIC -442.9%
FCF / Share $-0.27
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -1.08
info Valuation on last close. End-of-day price, Aug 6, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$30.38M
↓ -12.8%
Net Income Profit after all expenses
$-12.34M
↓ -680.8%
Operating Margin Operating profit as % of sales
-27.8%
↓ -267.2% 8th
FCF / Share Free cash flow per share
$-0.27
↑ +58.0%
Long-Term Debt Long-term obligations
$25.06M
↑ +236.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
9
Returns
97
Financial Health
69
Cash Quality
30

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 43 quarters